These distressing and heartbreaking figures affect fathers, sons, brothers, grandfathers, families and friends everywhere. With prostate cancer being the most common cancer among Australians after non-melanoma skin cancer, research into the disease has never been so vital.
We believe that every man diagnosed with prostate cancer deserves a better future.
Thanks to the generosity of our Mater Cars for Cancer supporters, the good news is we have already made great progress in enhancing the lives of men with prostate cancer. Together, we can improve the lives of men with prostate cancer by supporting research that is happening right now at Mater—research that could change the diagnosis, and prognosis, of men with prostate cancer in the future. Our world-class research institute—Mater Research— provides medical and clinical research that aims to translate their findings from ‘bench to bedside’ as quickly as possible; directly benefiting patients at Mater, across Australia and around the world. Mater’s researchers have been working around-the-clock to better understand, treat and ultimately prevent prostate cancer.
Development of a vaccine for prostate cancer: For the past 14 years, Associate Professor Radford and her team have been involved in an exciting, potentially life-changing Mater Research project. They have come a long way in developing a therapeutic vaccine which would enable a person’s immune system to kill cancer cells and eliminate them from the body. If successful, we could see the development of a ‘next generation’ therapeutic vaccination which would offer a practical, and more affordable, treatment approach for use in men with prostate cancer. The leading science publication Nature Medicine has heralded Associate Professor Radford’s discovery as ‘finding a needle in a haystack’.
Mapping the prostate cancer journey: Professor Janet Hardy and her team are leading a project at Mater Research, looking into the genetic basis of prostate cancer symptoms by analysing the genome of patients living with the disease. This research seeks to understand why some men suffer much worse symptoms than others who have a similar cancer. If successful, early symptom treatment could ease the burden of men’s prostate cancer symptoms, and improve their quality of life.
Looking at prostate cancer bone metastasis: In a promising breakthrough, Professor John Hooper and his team at Mater Research have discovered a cell receptor that promotes inflammation and is involved in the metastasis of prostate cancer to the bone—a location that cancer often spreads to. By better understanding this process, Professor Hooper and his team hope to slow down prostate cancer metastasis or prevent it from occurring.
Funds raised by the Mater Cars for Cancer lottery go towards providing care for cancer patients at Mater, as well as allowing Mater Research to stay at the forefront of cancer research and find ways to better diagnose and treat cancer.
Mater offers support to men with prostate cancer through our specialist Mater Cancer Care Centres located in Brisbane, Springfield and Redland. Here, men can access all of the medical care and support services they need in one convenient location. These highly specialised, state-of-the-art facilities provide men with comprehensive and compassionate care that is personalised to their individual needs. From oncology appointments to counselling, music and art therapy, occupational therapy, psychology and physiotherapy—these services are all part of Mater’s exceptional service delivery.
Together we can help fight cancer! By purchasing tickets in Mater Cars for Cancer lottery, you’re making a positive difference to the lives of thousands of people with cancer through investing in promising research happening right now at Mater. So buy your tickets today and you will also be in the chance to win yourself a brand new supercharged HSV Senator Signature enhanced by Walkinshaw Performance W507!